FDA Inspection 1276410 — Stryker Corporation

Stryker Corporation — FEI 3009390713

The FDA completed an inspection of Stryker Corporation on June 18, 2025 in Minnetonka, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 18, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Minnetonka, MN (United States)